Pediatric Mandibular Reconstruction Using the Vascularized Fibula Free Flap: Functional Outcomes in 34 Consecutive Patients

Conclusions The vascularized fibula free flap is reaffirmed to be the criterion standard for mandible reconstruction in pediatric patients, providing satisfactory functional results and adequate adaptation to the growing facial skeleton with minimal sequelae. Complications regarding hallux function may be prevented by assessing the vascularity of the flexor hallucis longus intraoperatively and ensuring tension-free closure of the donor site.
Source: Annals of Plastic Surgery - Category: Cosmetic Surgery Tags: Microsurgery Source Type: research

Related Links:

People who experience debilitating back pain come to their doctors with one pressing question: Do I need back surgery? Often, they are surprised to hear me, a neurosurgeon, answer, “No.” In many cases, physical therapy, pain management, weight loss management, and physiatry can help people to delay – and in some cases avoid – backRead more …Expertise is the backbone of successful spine treatment originally appeared inKevinMD.com.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions Neurosurgery Orthopedics Source Type: blogs
I am noticing alot of new hybrid dpt programs. I am assuming it is because of the pandemic. I was wondering if this would harm the profession in any sort of way. Will we see more saturation in the future?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pre-Physical Therapy Source Type: forums
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
Condition:   Sarcoma, Soft Tissue Intervention:   Drug: Recombinant anti-PD-1 humanized monoclonal antibody injection Sponsor:   Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Diffuse Large B-cell Lymphoma Intervention:   Drug: GNC-038 Sponsors:   Sichuan Baili Pharmaceutical Co., Ltd.;   SystImmune Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Sarcoma, Soft Tissue Intervention:   Drug: Recombinant anti-PD-1 humanized monoclonal antibody injection Sponsor:   Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conclusions Based on this work, our opinion is that the choice to undergo the patients to ChT combined to surgery could improve their prognosis.
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research
CONCLUSION: Moderate doses of radiotherapy are curative in early-stage orbital MALT lymphoma with favorable clinical outcomes. Lower doses of radiation can reduce the toxicity further, without compromising efficacy.PMID:35027338 | DOI:10.1016/j.clml.2021.12.013
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research
CONCLUSION: Among patients with lymphoid malignancies undergoing HSCT, frailty was associated with greater in-hospital mortality, longer length of stay, and higher hospitalization costs. Comprehensive health status assessments for identifying and managing frail patients in this population could improve patient outcomes.PMID:35027337 | DOI:10.1016/j.clml.2021.12.017
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research
J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0777. Online ahead of print.NO ABSTRACTPMID:35029149 | DOI:10.18176/jiaci.0777
Source: Journal of Investigational Allergology and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research
More News: Brain | Fibroma | Lymphoma | Neurology | Neurosurgery | Pediatrics | Physical Therapy | Plastic Surgery | Sarcomas | Study | Temporomandibular Disorders